AstraZeneca PLC (AZN)

55.41 -0.80  -1.42% NYSE Aug 7, 20:00 USD

AstraZeneca Cash from Financing (Quarterly):

1.126B for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 1.126B
March 31, 2020 -2.362B
Dec. 31, 2019 6.00M
Sept. 30, 2019 -2.712B
June 30, 2019 1.639B
March 31, 2019 -698.00M
Dec. 31, 2018 -1.732B
Sept. 30, 2018 169.00M
June 30, 2018 182.00M
March 31, 2018 -663.00M
Dec. 31, 2017 -12.00M
Sept. 30, 2017 -3.07B
June 30, 2017 2.188B
March 31, 2017 -2.042B
Dec. 31, 2016 -304.00M
Sept. 30, 2016 -1.014B
June 30, 2016 1.355B
March 31, 2016 -1.361B
Dec. 31, 2015 4.284B
Sept. 30, 2015 -1.018B
June 30, 2015 181.00M
March 31, 2015 -2.569B
Dec. 31, 2014 1.151B
Sept. 30, 2014 -1.286B
June 30, 2014 -358.00M
   
March 31, 2014 -2.212B
Dec. 31, 2013 201.00M
Sept. 30, 2013 -1.112B
June 30, 2013 96.00M
March 31, 2013 -2.232B
Dec. 31, 2012 -525.00M
Sept. 30, 2012 -242.00M
June 30, 2012 -718.00M
March 31, 2012 -3.438B
Dec. 31, 2011 -1.681B
Sept. 30, 2011 -2.85B
June 30, 2011 -983.00M
March 31, 2011 -3.807B
Dec. 31, 2010 -1.82B
Sept. 30, 2010 -1.731B
June 30, 2010 -445.00M
March 31, 2010 -3.338B
Dec. 31, 2009 64.00M
Sept. 30, 2009 -1.47B
June 30, 2009 31.00M
March 31, 2009 -2.254B
Dec. 31, 2008 -1.463B
Sept. 30, 2008 -2.345B
June 30, 2008 -159.00M
March 31, 2008 -2.395B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Benchmarks

Benchmarks
GlaxoSmithKline PLC -3.216B
Emergent BioSolutions Inc 4.70M
Gilead Sciences Inc -874.00M

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum -3.07B Sep 2017
Maximum 4.284B Dec 2015
Average -301.95M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.